Sinopharm (01099): China National Pharmaceutical Group's operating profit in the first three quarters was 962 million yuan, a year-on-year decrease of 10.34%.

Sinopharm (01099) announced that its subsidiary, China Medical Device Co., Ltd. (Sinopharm Medical Device), achieved operating income of RMB 54.693 billion for the nine months ended September 30, 2025, a decrease of 2.41% year-on-year; operating profit was RMB 0.962 billion, down by 10.34% year-on-year; total comprehensive income attributable to owners of the parent company was RMB 0.395 billion, down by 2.71% year-on-year.